| P2093 | author name string | Daria La Torre | |
| P2860 | cites work | Journal of Clinical Investigation | Q3186904 |
| | American Journal of Human Genetics | Q4744249 |
| | Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes | Q79553721 |
| | No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes | Q79843142 |
| | Reduced IFN-alpha secretion by blood dendritic cells in human diabetes | Q79963070 |
| | From vanilla to 28 flavors: multiple varieties of T regulatory cells | Q80141724 |
| | Decreased blood dendritic cell counts in type 1 diabetic children | Q80226211 |
| | Dendritic cells in human thymus and periphery display a proinsulin epitope in a transcription-dependent, capture-independent fashion | Q81008941 |
| | Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes | Q81464244 |
| | Detection of enteroviruses in the intestine of type 1 diabetic patients | Q81572286 |
| | Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population | Q81716770 |
| | Altered Toll-like receptor signaling pathways in human type 1 diabetes | Q84775923 |
| | Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA | Q22010440 |
| | CD40 AND CD154 IN CELL-MEDIATED IMMUNITY | Q22255634 |
| | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
| | Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes | Q24632382 |
| | The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes | Q24675521 |
| | CTLA-4 ligation blocks CD28-dependent T cell activation | Q24678229 |
| | APC-derived cytokines and T cell polarization in autoimmune inflammation | Q24679426 |
| | T-Cell Epitopes in Type 1 Diabetes Autoantigen Tyrosine Phosphatase IA-2: Potential for Mimicry with Rotavirus and Other Environmental Agents | Q27485358 |
| | Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen | Q28210683 |
| | Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies | Q28237011 |
| | Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? | Q28242617 |
| | The role of the CD28 receptor during T cell responses to antigen | Q28263234 |
| | A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study | Q28264836 |
| | TH17 cells in development: an updated view of their molecular identity and genetic programming | Q28276449 |
| | Environmental triggers and determinants of type 1 diabetes | Q28283357 |
| | The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens | Q73621908 |
| | Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes | Q73810102 |
| | Development of type 1 diabetes despite severe hereditary B-cell deficiency | Q74593633 |
| | Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study | Q74607777 |
| | Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY) | Q75346111 |
| | High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes | Q78290524 |
| | Association of the PTPN22/LYP gene with type 1 diabetes | Q79281980 |
| | Use of microarray analysis to unveil transcription factor and gene networks contributing to Beta cell dysfunction and apoptosis | Q79370236 |
| | T-cell activation through immunological synapses and kinapses | Q37084875 |
| | The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 |
| | IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells | Q37089982 |
| | The natural history of type 1A diabetes | Q37148312 |
| | Advances in type I diabetes associated tolerance mechanisms | Q37164758 |
| | PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis | Q37193767 |
| | Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes | Q37196719 |
| | Autoimmune mechanisms in type 1 diabetes | Q37215820 |
| | Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A | Q37245361 |
| | IL-1 produced and released endogenously within human islets inhibits beta cell function | Q37384207 |
| | Role of innate immunity in triggering and tuning of autoimmune diabetes | Q37387450 |
| | Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. | Q37400735 |
| | Aire | Q37419376 |
| | Histopathology of type 1 diabetes: old paradigms and new insights | Q37425106 |
| | The role of inflammation in insulitis and beta-cell loss in type 1 diabetes | Q37437153 |
| | IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus | Q37518209 |
| | ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset | Q37520312 |
| | Are B cells a potential target for therapeutic intervention in the classical T cell-mediated autoimmune disease type 1 diabetes? | Q37521124 |
| | Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. | Q37779881 |
| | Type 1 diabetes: etiology, immunology, and therapeutic strategies | Q37830198 |
| | Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family | Q37864700 |
| | Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature | Q38569312 |
| | Insulin autoantibodies: their role in the pathogenesis of IDDM. | Q39678759 |
| | Testing the NKT cell hypothesis of human IDDM pathogenesis | Q39738424 |
| | Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study | Q39975295 |
| | Determinant spreading and the dynamics of the autoimmune T-cell repertoire. | Q40487702 |
| | Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus | Q40494326 |
| | Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient | Q40607014 |
| | Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope | Q40720812 |
| | Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. | Q40724749 |
| | Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays | Q40797897 |
| | Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 |
| | Adhesion molecules in autoimmune disease | Q41133422 |
| | Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases | Q43089300 |
| | Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group | Q43607374 |
| | Dietary microbial toxins and type 1 diabetes--a new meaning for seed and soil | Q43763539 |
| | Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production | Q43867519 |
| | A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland | Q43899034 |
| | Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease | Q44110178 |
| | Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes | Q44616498 |
| | GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. | Q44876645 |
| | Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects | Q44887481 |
| | Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects | Q44914587 |
| | CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope | Q44937301 |
| | Milk Proteins in the Etiology of Insulin-Dependent Diabetes Mellitus (IDDM) | Q36689792 |
| | Identification of novel IGRP epitopes targeted in type 1 diabetes patients. | Q36725757 |
| | Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes | Q36755911 |
| | The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes | Q36807498 |
| | Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. | Q36815557 |
| | PD-1 and PD-1 ligands: from discovery to clinical application | Q36868261 |
| | Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins | Q36905127 |
| | B-cell self-tolerance in humans | Q36942517 |
| | Dendritic cells: understanding immunogenicity | Q36986703 |
| | Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe? | Q37022995 |
| | Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture | Q37023012 |
| | Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes | Q37066897 |
| | Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 |
| | Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs | Q28359868 |
| | Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion | Q28510538 |
| | Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis | Q29011023 |
| | T-Cell Function and Migration — Two Sides of the Same Coin | Q29041098 |
| | FOXP3+ regulatory T cells in the human immune system | Q29307487 |
| | Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes | Q29417127 |
| | IDO expression by dendritic cells: tolerance and tryptophan catabolism | Q29614752 |
| | Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 |
| | The effect of infections on susceptibility to autoimmune and allergic diseases | Q29618525 |
| | Results of the MHC fine mapping workshop. | Q30438545 |
| | Genetics of type 1A diabetes | Q30448199 |
| | Antibodies to SOX13 (ICA12) are associated with type 1 diabetes. | Q30660084 |
| | Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends | Q31473026 |
| | Mapping of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by peptide phage display and molecular modeling: overlap of antibody and T cell determinants | Q33199893 |
| | Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery. | Q33321888 |
| | Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes | Q33383716 |
| | Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1. | Q33586528 |
| | Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes | Q33840423 |
| | Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients | Q33907823 |
| | The Environmental Determinants of Diabetes in the Young (TEDDY) Study | Q33917733 |
| | Childhood Vaccinations, Vaccination Timing, and Risk of Type 1 Diabetes Mellitus | Q34103885 |
| | Information transfer at the immunological synapse. | Q34117443 |
| | CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity? | Q34150490 |
| | Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes | Q34159440 |
| | Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes | Q34234705 |
| | Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity | Q34262463 |
| | Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies | Q34266396 |
| | T cell-dependent B cell activation | Q34363600 |
| | Enterovirus RNA in blood is linked to the development of type 1 diabetes | Q34448707 |
| | A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis | Q34495385 |
| | Tolerogenic dendritic cells: cytokine modulation comes of age. | Q34523591 |
| | Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. | Q34553677 |
| | Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 |
| | Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 |
| | Screening for insulitis in adult autoantibody-positive organ donors | Q34580251 |
| | Viral infections as potential triggers of type 1 diabetes | Q34581550 |
| | A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene | Q34651283 |
| | Historical insights into cytokines | Q34708047 |
| | Environmental factors in the etiology of type 1 diabetes | Q34737247 |
| | Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells | Q34737266 |
| | Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes | Q34737274 |
| | GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes | Q34790295 |
| | Viral trigger for type 1 diabetes: pros and cons | Q34868678 |
| | Analysis of islet inflammation in human type 1 diabetes. | Q34917032 |
| | The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. | Q34957941 |
| | A new look at viruses in type 1 diabetes. | Q35068487 |
| | Dietary factors and the risk of developing insulin dependent diabetes in childhood | Q35169227 |
| | Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes | Q35172147 |
| | A comprehensive guide to antibody and T-cell responses in type 1 diabetes. | Q35583448 |
| | Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus | Q35608673 |
| | Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health | Q35632007 |
| | MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete | Q35718644 |
| | Environmental causes: dietary causes | Q35725717 |
| | Tissue targeting of T cells by DCs and microenvironments | Q35846381 |
| | Toward an understanding of NKT cell biology: progress and paradoxes | Q36072480 |
| | Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens | Q36111731 |
| | Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase | Q36202374 |
| | Immunoregulation of dendritic cells | Q36256306 |
| | Cross-presentation: underlying mechanisms and role in immune surveillance | Q36266474 |
| | Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes | Q36310443 |
| | Autoimmune destruction of pancreatic beta cells. | Q36310464 |
| | Type 1 diabetes mellitus: etiology, presentation, and management | Q36318729 |
| | Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes | Q36364761 |
| | The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes | Q36535592 |
| | Autoantibody markers for the diagnosis and prediction of type 1 diabetes | Q36557401 |
| | Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. | Q36563563 |
| | A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. | Q36666034 |
| | NK cells and type 1 diabetes | Q36680559 |
| | A fifty-year follow-up of congenital rubella | Q45094875 |
| | A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families | Q45138861 |
| | Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM | Q45236628 |
| | Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop | Q45256424 |
| | No Evidence for an Association of Coxsackie Virus Infections during Pregnancy and Early Childhood with Development of Islet Autoantibodies in Offspring of Mothers or Fathers with Type 1 Diabetes | Q45734292 |
| | Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. | Q45771753 |
| | Coxsackie B virus infection and onset of childhood diabetes | Q45787981 |
| | Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes. | Q46009178 |
| | The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. | Q46085427 |
| | Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. | Q46677005 |
| | Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes | Q46739819 |
| | The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic | Q46953270 |
| | Good riddance: Thymocyte clonal deletion prevents autoimmunity | Q47946468 |
| | Immunology in diabetes: an update | Q48030355 |
| | Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. | Q51559700 |
| | Number of islet autoantibodies present in newly diagnosed type 1 diabetes children born to non-diabetic mothers is affected by islet autoantibodies present at birth | Q51717930 |
| | Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes | Q51977695 |
| | The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes | Q52196097 |
| | Insulin autoantibodies and insulin antibodies have similar binding characteristics | Q52227031 |
| | Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity | Q54084991 |
| | Altered natural killer cells in type 1 diabetic patients | Q54565253 |
| | Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus | Q54568509 |
| | Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. | Q55044269 |
| | Interferons induce an antiviral state in human pancreatic islet cells | Q56875360 |
| | Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes | Q56902091 |
| | Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes | Q56904461 |
| | Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups | Q56908296 |
| | GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects | Q57158887 |
| | Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies | Q57449132 |
| | Poor In Vitro Maturation and Pro-Inflammatory Cytokine Response of Dendritic Cells in Children at Genetic Risk of Type 1 Diabetes | Q57449379 |
| | Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function | Q57491711 |
| | Islet inflammation and CXCL10 in recent-onset type 1 diabetes | Q57503559 |
| | Cognate CD4+ T-cell-dendritic cell interactions induce migration of immature dendritic cells through dissolution of their podosomes | Q58470464 |
| | Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes | Q61861625 |
| | Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study | Q64378313 |
| | In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis | Q67296143 |
| | Feeding in infancy and the risk of type 1 diabetes mellitus in Finnish children. The 'Childhood Diabetes in Finland' Study Group | Q67975292 |
| | Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Experimental induction of anti-pancreatic, cellular hypersensitivity and associated morphological B-cell changes in the rat | Q69324742 |
| | Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans | Q70291006 |
| | Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes | Q71557208 |
| | Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus | Q71670371 |
| | Autoantibodies to IA-2 in IDDM: location of major antigenic determinants | Q71909260 |
| | Nitrate and nitrite intake and the risk for type 1 diabetes in Finnish children. Childhood Diabetes in Finland Study Group | Q72793959 |
| | Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells | Q73048880 |
| | Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus | Q73153922 |
| | Type 1 diabetes alters anti-hsp90 autoantibody isotype | Q73407950 |
| | Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group | Q73420339 |
| | T cells and autoantibodies to human HSP70 in type 1 diabetes in children | Q73489749 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 194-218 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Immunobiology of beta-cell destruction | |
| | Immunobiology of β-Cell Destruction | |
| P478 | volume | 771 | |